Common marmoset monkeys (Callithrix jacchus) share great anatomical and physiological similarities to humans in comparison to laboratory rodents. Furthermore, marmosets show high homologies of target structures to highly human-specific therapeutics. Thus, we investigated whether the common marmoset monkey represents a valid non-human primate model to study inflammatory respiratory diseases. Acute ex vivo and in vivo lipopolysaccharide (LPS)-induced inflammation models of the lung have been developed to adapt pre-clinical models closer to the human situation.
Introduction

Methods
Marmosets and humans exhibited significant similarities in PCLS regarding cytokine secretion after acute LPS exposure.
Acute intrabronchial LPS exposure of marmosets in vivo caused a local respiratory response with influx of neutrophils and increase of TNF-α.
Therapeutic intervention with roflumilast and dexamethasone modulates LPS-induced TNF-α release ex vivo and in vivo.
Roflumilast significantly diminished LPS-induced neutrophilia.
Marmoset monkeys represent a promising model to study pharmacological issues of human inflammatory airway diseases.
LPS instillation caused a significant influx of neutrophils (Fig 3 A,  B ) and increased TNF-α concentration in BAL fluid after 18 hours (Fig. 3 C) compared to baseline levels. No signs of systemic toxicity were observed. Roflumilast and dexamethasone treatment reduced LPS-induced neutrophilia and TNF-α increase in BAL. Read-out:
Conclusion
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Results
Marmoset precision cut lung slices (PCLS) revealed a dosedependent TNF-α release after stimulation with LPS (Fig. 2 A) , which was significantly decreased after treatment with dexamethasone ( Fig. 2 B) . Data obtained from marmoset showed significant correlations with LPS-treated human PCLS (R²>0.9) (Fig. 2 C) . The phoshodiesterase-4-inhibitor roflumilast reduced TNF-α secretion in human and marmoset PCLS dosedependently and showed similar EC 50 values. (Fig. 2 D) . 
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